Email updates

Keep up to date with the latest news and content from JTM and BioMed Central.

This article is part of the supplement: 7th European Workshop on Immune-Mediated Inflammatory Diseases

Open Access Open Badges Oral presentation

NF-kappaB inducing kinase (NIK) is a key regulator of inflammation-induced angiogenesis

Ae-Ri Noort1, Katinka PM van Zoest1, Pieter Koolwijk2, Paul-Peter Tak1 and Sander W Tas1*

  • * Corresponding author: Sander W Tas

Author Affiliations

1 Division of Clinical Immunology & Rheumatology, Academic Medical Center, University of Amsterdam, The Netherlands

2 Dept. of Physiology, Institute for Cardiovascular Research (ICaR-VU), VU University Medical Center, Amsterdam, The Netherlands

For all author emails, please log on.

Journal of Translational Medicine 2012, 10(Suppl 3):O1  doi:10.1186/1479-5876-10-S3-O1

The electronic version of this article is the complete one and can be found online at:

Published:28 November 2012

© 2012 Noort et al; licensee BioMed Central Ltd.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


In rheumatoid arthritis (RA) synovial tissue (ST) angiogenesis can be observed already in the earliest phase of disease. The chemokine CXCL12, which is induced via the non-canonical nuclear factor-kappaB (NF-kB) pathway, plays an important role in angiogenesis, lymphocyte transendothelial migration, and the homing of endothelial progenitor cells. Therefore, the non-canonical pathway, with its key mediator NF-kB inducing kinase (NIK), may play an important role in pathological angiogenesis and the perpetuation of synovial inflammation in RA.


To study the role of non-canonical NF-kB signaling in pathological angiogenesis in RA.


Expression of NIK and CXCL12 in RA ST was evaluated using immunofluorescence microscopy (IF). Angiogenesis was studied in endothelial cells (EC) in vitro using the tube formation assay and ex vivo by comparing WT and NIK-/- mice in the aortic ring assay. Physiological (developmental) angiogenesis was evaluated by isolectin B4 staining of the retina followed by confocal microscopy. The contribution of NIK to synovial angiogenesis was studied in vivo in antigen-induced arthritis (AIA).


NIK, p52 and CXCL12 were highly expressed in EC in RA ST, mainly in small (newly formed) blood vessels. Stimuli that induce non-canonical NF-kB signaling (lymphotoxin (LT), LIGHT, and CD40L) significantly enhanced in vitro tube formation 2,5-fold (p<0.05), which could be completely blocked by siRNA targeting NIK or IKKα. Aortic rings from WT and NIK-/- mice showed normal TNF- and VEGF-induced microvessel outgrowth. In contrast, whereas non-canonical NF-kB stimuli induced microvessel outgrowth in WT mice (unstim 29.94 ± 6.08 vs. LT 159.1 ± 50.24 vs. LIGHT 110.3 ± 17.68 (mm^2) p<0.05), no microvessel outgrowth was observed in aortic rings from NIK-/- mice (unstim 28.74 ± 15.89 vs. LT 45.9 ± 16.71 vs. LIGHT 43.41 ± 15.73 (mm^2)). In line with this, NIK-/- mice exhibited normal developmental angiogenesis in the retina, but a 50% reduction in pathological angiogenesis in synovial inflammation (blood vessels in synovial tissue WT 20 ± 5.07 vs. NIK-/- 10.2 ± 3.02).


NIK is preferentially expressed in EC in RA ST and non-canonical NF-kB signaling in EC results in enhanced angiogenesis in vitro. NIK-/- mice exhibited normal developmental and VEGF-induced angiogenesis, but reduced pathological angiogenesis in AIA. These findings point towards an important role of the non-canonical NF-kB pathway in pathological angiogenesis associated with chronic (synovial) inflammation. This could be exploited for the development of future new therapies for RA.